Cash flow Perspective Therapeutics, Inc.

Stocks

CATX

US46489V3024

Biotechnology & Medical Research

Market Closed - NYSE Other stock markets 01:30:00 31/07/2026 am IST			5-day change	1st Jan Change
2.990 ^USD	+4.18%		+1.36%	+8.73%

28/07	Perspective Therapeutics' Neuroendocrine Tumor Therapy Receives EU Orphan Drug Designation	MT
17/07	Perspective Therapeutics Data On 212Pb VMT-a-NET Accepted For Oral Presentation At ESMO Congress 2026	CI

90f11b8a91d23399235816.VWYItiYUA7N3R7ZnrypOhcmwl3D_teu0K3V1-c9tvlQ.H1VQ228ibJ4jMtNV6ht915vk9TPH5oaCfRo4lbsL5hIEHzzFbiVT4A4M-w

Published financial data: PERSPECTIVE THERAPEUTICS, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	1.01Cr	71.04L	14.34L	14.54L	9L
Total Revenues	1.01Cr	71.04L	14.34L	14.54L	9L
Cost of Goods Sold, Total	49.32L	54.7L	-	3.94Cr	8.42Cr
Gross Profit	51.21L	16.34L	14.34L	-3.8Cr	-8.33Cr
Selling General & Admin Expenses, Total	71.31L	1.42Cr	2.11Cr	2.66Cr	3.02Cr
R&D Expenses	14.27L	26.02L	2.13Cr	22.09L	-
Other Operating Expenses	-	-	-	-	-
Other Operating Expenses, Total	85.58L	1.68Cr	4.24Cr	2.88Cr	3.02Cr
Operating Income	-34.37L	-1.52Cr	-4.09Cr	-6.68Cr	-11Cr
Interest Expense, Total	-	-	-84T	-48T	-4L
Interest And Investment Income	59T	11.22L	9L	1.05Cr	81.14L
Net Interest Expenses	59T	11.22L	8L	1.05Cr	77.38L
Income (Loss) On Equity Invest.	-	-	-17T	-8T	-2T
Other Non Operating Income (Expenses)	-	-	2T	-	14L
EBT, Excl. Unusual Items	-33.78L	-1.41Cr	-4.01Cr	-5.63Cr	-10Cr
Restructuring Charges	-	-	-	-	-
Impairment of Goodwill	-	-	-	-2.41Cr	-
Gain (Loss) On Sale Of Assets	-9T	-6L	-	-27T	-
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	-33.87L	-1.47Cr	-4.01Cr	-8.04Cr	-10Cr
Income Tax Expense	-	-	-26.51L	-20.97L	-8L
Earnings From Continuing Operations	-33.87L	-1.47Cr	-3.75Cr	-7.83Cr	-10Cr
Earnings Of Discontinued Operations	-	-	-90.53L	-9L	5L
Net Income to Company	-33.87L	-1.47Cr	-4.65Cr	-7.93Cr	-10Cr
Net Income - (IS)	-33.87L	-1.47Cr	-4.65Cr	-7.93Cr	-10Cr
Preferred Dividend and Other Adjustments	3T	-	-	-	-
Net Income to Common Incl Extra Items	-33.9L	-1.47Cr	-4.65Cr	-7.93Cr	-10Cr
Net Income to Common Excl. Extra Items	-33.9L	-1.47Cr	-3.75Cr	-7.83Cr	-10Cr
Per Share Items
Net EPS - Basic	-0.33	-1.03	-1.74	-1.23	-1.4
Basic EPS - Continuing Operations	-0.33	-1.03	-1.4	-1.22	-1.4
Basic Weighted Average Shares Outstanding	1.04Cr	1.42Cr	2.68Cr	6.44Cr	7.38Cr
Net EPS - Diluted	-0.33	-1.03	-1.74	-1.23	-1.4
Diluted EPS - Continuing Operations	-0.33	-1.03	-1.4	-1.22	-1.4
Diluted Weighted Average Shares Outstanding	1.04Cr	1.42Cr	2.68Cr	6.44Cr	7.38Cr
Normalized Basic EPS	-0.2	-0.62	-0.94	-0.55	-0.88
Normalized Diluted EPS	-0.2	-0.62	-0.94	-0.55	-0.88
Payout Ratio	-0.27	-	-	-	-
Supplemental Items
EBITDA	-32.27L	-1.48Cr	-4Cr	-6.45Cr	-11Cr
EBITA	-33.76L	-1.51Cr	-4.09Cr	-6.68Cr	-11Cr
EBIT	-34.37L	-1.52Cr	-4.09Cr	-6.68Cr	-11Cr
EBITDAR	-29.23L	-72.58L	-3.99Cr	-6.37Cr	-11Cr
Effective Tax Rate - (Ratio)	-	-	6.61	2.61	0.76
Deferred Domestic Taxes	-	-	-26.51L	-20.97L	-8L
Total Deferred Taxes	-	-	-26.51L	-20.97L	-8L
Normalized Net Income	-21.11L	-87.88L	-2.51Cr	-3.52Cr	-6.53Cr
Interest on Long-Term Debt	-	-	84T	-	-
Supplemental Operating Expense Items
Marketing Expenses	84T	1L	-	-	-
Selling and Marketing Expenses	24.4L	32.28L	-	-	-
General and Administrative Expenses	45.82L	1.09Cr	2.1Cr	2.58Cr	2.91Cr
Research And Development Expense From Footnotes	14.27L	26.02L	2.13Cr	4.16Cr	8.42Cr
Net Rental Expense, Total	3L	2L	97T	8L	11L
Imputed Operating Lease Interest Expense	-	-	-	92.9T	9L
Imputed Operating Lease Depreciation	-	-	-	7L	2L
Stock-Based Comp., COGS (Total)	30T	28T	-	-	39.45L
Stock-Based Comp., R&D Exp. (Total)	1L	3L	10L	22.09L	-
Stock-Based Comp., S&M Exp. (Total)	49T	94T	-	-	-
Stock-Based Comp., G&A Exp. (Total)	2L	9L	21.75L	30.12L	50.21L
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	4L	13.44L	31.43L	52.21L	89.66L

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	6.38Cr	2.1Cr	92.38L	6.16Cr	3.06Cr
Short Term Investments	-	2.28Cr	-	17Cr	11Cr
Total Cash And Short Term Investments	6.38Cr	4.38Cr	92.38L	23Cr	14Cr
Accounts Receivable, Total	20.13L	13.63L	11.65L	1L	6T
Other Receivables	32T	2T	10T	13.67L	10.33L
Notes Receivable	-	61.09L	-	-	-
Total Receivables	20.45L	74.74L	11.75L	14.83L	10.39L
Inventory	10L	14.09L	-	-	-
Prepaid Expenses	4L	5L	10.78L	26.8L	25.78L
Other Current Assets, Total	27T	27T	53.46L	81T	35T
Total Current Assets	6.73Cr	5.32Cr	1.68Cr	23Cr	15Cr
Gross Property Plant And Equipment	99.74L	96.93L	69.92L	6.25Cr	8.43Cr
Accumulated Depreciation	-72.48L	-76.31L	-7L	-29.6L	-62.04L
Net Property Plant And Equipment	27.26L	20.62L	63.23L	5.95Cr	7.81Cr
Long-term Investments	-	2L	1L	1L	1L
Goodwill	-	-	2.41Cr	-	-
Other Intangibles, Total	1L	86T	5.04Cr	5Cr	4Cr
Other Long-Term Assets, Total	3L	25.78L	2L	3L	4L
Total Assets	7.04Cr	5.81Cr	9.79Cr	34Cr	27Cr
Liabilities
Accounts Payable, Total	7L	15.41L	61.07L	98.43L	2.03Cr
Accrued Expenses, Total	8L	9L	43.9L	54.78L	74.89L
Current Portion of Long-Term Debt	-	-	49T	52T	56T
Current Portion of Leases	3L	3L	46T	10L	6L
Unearned Revenue Current, Total	-	-	-	14L	-
Other Current Liabilities	-	-	50.72L	5L	2L
Total Current Liabilities	18.01L	26.76L	1.57Cr	1.82Cr	2.87Cr
Long-Term Debt	-	-	16.76L	16.25L	15.69L
Long-Term Leases	5L	1L	8L	14.28L	10.05L
Unearned Revenue Non Current	-	-	-	2.66Cr	2.66Cr
Deferred Tax Liability Non Current	-	-	45.92L	24.95L	17.02L
Other Non Current Liabilities	7L	7L	-	55T	4L
Total Liabilities	30.1L	34.49L	2.27Cr	5.04Cr	5.99Cr
Preferred Stock Convertible	-	-	-	-	-
Total Preferred Equity	-	-	-	-	-
Common Stock, Total	1L	1L	3L	70T	74T
Additional Paid In Capital	16Cr	16Cr	23Cr	52Cr	54Cr
Retained Earnings	-9.13Cr	-11Cr	-15Cr	-23Cr	-33Cr
Comprehensive Income and Other	-	-	-	-51T	1L
Total Common Equity	6.74Cr	5.46Cr	7.52Cr	29Cr	21Cr
Total Equity	6.74Cr	5.46Cr	7.52Cr	29Cr	21Cr
Total Liabilities And Equity	7.04Cr	5.81Cr	9.79Cr	34Cr	27Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.42Cr	2.8Cr	5.87Cr	7.41Cr	11Cr
ECS Total Common Shares Outstanding	1.42Cr	1.42Cr	2.82Cr	7.07Cr	7.43Cr
Book Value / Share	4.75	3.84	2.67	4.11	2.78
Tangible Book Value	6.73Cr	5.46Cr	8L	24Cr	17Cr
Tangible Book Value Per Share	4.74	3.84	0.03	3.41	2.25
Total Debt	8L	4L	25.51L	40.62L	32.53L
Net Debt	-6.31Cr	-4.34Cr	-66.87L	-22Cr	-14Cr
Debt Equivalent Oper. Leases	24.32L	24.96L	8L	64L	88L
Equity Method Investments, Total	-	2L	1L	1L	1L
Account Code - Inventory Valuation	6	6	6	6	3
Inventories - Raw Materials, Total	6L	8L	-	-	-
Inventories - Work In Process, Total	3L	6L	-	-	-
Inventories - Finished Goods, Total	49T	21T	-	-	-
Land - (BS)	4L	4L	12.83L	9L	9L
Buildings, Total	-	-	17.7L	17.7L	17.7L
Machinery, Total	42.02L	45.81L	26.83L	1.14Cr	1.55Cr
Full Time Employees	61	66	116	138	163
Part Time Employees	-	-	3	2	3
Accumulated Allowance for Doubtful Accounts (Supple)	26T	26T	6L	5L	4L

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-33.87L	-1.47Cr	-4.65Cr	-7.93Cr	-10Cr
Depreciation & Amortization - CF	1L	3L	9L	22.99L	32.44L
Amortization of Goodwill and Intangible Assets - (CF)	61T	68T	35T	-	-
Depreciation & Amortization, Total	2L	3L	10L	22.99L	32.44L
Amortization of Deferred Charges, Total - (CF)	7T	8T	7T	7T	7T
(Gain) Loss From Sale Of Asset	10T	6L	22T	27T	-
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-6L	-27.23L
Asset Writedown & Restructuring Costs	-	-	-	2.41Cr	-
(Income) Loss On Equity Investments - (CF)	-	-	17T	-	-
Stock-Based Compensation (CF)	4L	13.44L	37.38L	52.21L	89.66L
Provision and Write-off of Bad Debts	-	-	6L	-	-
Net Cash From Discontinued Operations	-	-	33T	2L	-
Other Operating Activities, Total	4T	-4L	18.77L	-20.63L	94.62L
Change In Accounts Receivable	31T	5L	-4L	10.49L	1L
Change In Inventories	-3L	-2L	4L	-	-
Change In Accounts Payable	76T	11.46L	15.84L	18.9L	1L
Change in Unearned Revenues	-	-	-	2.8Cr	-14L
Change in Other Net Operating Assets	1L	-8L	8L	9L	28.24L
Cash from Operations	-28.37L	-1.22Cr	-3.69Cr	-1.83Cr	-8.25Cr
Capital Expenditure	-4L	-3L	-10.72L	-5.44Cr	-1.27Cr
Sale of Property, Plant, and Equipment	1T	-	-	3L	-
Cash Acquisitions	-	-	26.99L	-	-
Sale (Purchase) of Intangible assets	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-	-4.54Cr	2.28Cr	-16Cr	5.41Cr
Other Investing Activities, Total	-30T	-1.2Cr	-18T	-72T	-1L
Cash from Investing	-4L	-5.77Cr	2.44Cr	-22Cr	4.12Cr
Long-Term Debt Repaid, Total	-	-	-68T	-48T	-52T
Total Debt Repaid	-	-	-68T	-48T	-52T
Issuance of Common Stock	6.47Cr	56T	6L	28Cr	1.04Cr
Preferred Dividends Paid	-9T	-	-	-	-
Common & Preferred Stock Dividends Paid	-9T	-	-	-	-
Other Financing Activities, Total	-	-	3L	1.22Cr	-
Cash from Financing	6.47Cr	56T	8L	29Cr	1.03Cr
Net Change in Cash	6.14Cr	-6.98Cr	-1.18Cr	5.22Cr	-3.1Cr
Supplemental Items
Cash Interest Paid	-	-	84T	-	-
Levered Free Cash Flow	-20.75L	-29.93L	-82.72L	-8.37Cr	-6.04Cr
Unlevered Free Cash Flow	-20.75L	-29.93L	-82.19L	-8.36Cr	-6.01Cr
Change In Net Working Capital	1L	-5L	-1.43Cr	-50.07L	-1.14Cr
Net Debt Issued / Repaid	-	-	-68T	-48T	-52T

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-5.43	-6.85	-32.81	-19.02	-23.34
Return on Total Capital	-5.74	-7.11	-38.66	-22.42	-28.11
Return On Equity %	-9.26	-11.3	-57.7	-42.82	-41.65
Return on Common Equity	-9.27	-11.3	-57.7	-42.82	-41.65
Margin Analysis
Gross Profit Margin %	50.94	23	100	-2.61T	-9.43T
SG&A Margin	70.93	200.08	1.47T	1.83T	3.42T
EBITDA Margin %	-32.1	-208.87	-2.79T	-4.44T	-12.48T
EBITA Margin %	-33.58	-212.75	-2.85T	-4.59T	-12.85T
EBIT Margin %	-34.19	-213.71	-2.86T	-4.59T	-12.85T
Income From Continuing Operations Margin %	-33.69	-206.5	-2.61T	-5.39T	-11.72T
Net Income Margin %	-33.69	-206.5	-3.24T	-5.45T	-11.67T
Net Avail. For Common Margin %	-33.72	-206.5	-2.61T	-5.39T	-11.72T
Normalized Net Income Margin	-21	-123.7	-1.75T	-2.42T	-7.38T
Levered Free Cash Flow Margin	-20.64	-27.73	-576.82	-5.75T	-6.83T
Unlevered Free Cash Flow Margin	-20.64	-27.73	-573.16	-5.75T	-6.8T
Asset Turnover
Asset Turnover	0.25	0.16	0.02	0.01	0
Fixed Assets Turnover	3.68	4.14	0.43	0.04	0.01
Receivables Turnover (Average Receivables)	4.96	5.96	1.13	2.27	14.49
Inventory Turnover (Average Inventory)	6.07	5.2	-	-	-
Short Term Liquidity
Current Ratio	37.37	19.89	1.07	12.68	5.17
Quick Ratio	36.58	16.86	0.66	12.53	5.08
Operating Cash Flow to Current Liabilities	-1.58	-4.55	-2.36	-1	-2.88
Days Sales Outstanding (Average Receivables)	73.65	61.22	321.73	161.23	25.19
Days Outstanding Inventory (Average Inventory)	60.13	70.18	-	-	-
Average Days Payable Outstanding	47.96	46.93	-	75.43	65.35
Cash Conversion Cycle (Average Days)	85.82	84.46	-	-	-
Long Term Solvency
Total Debt/Equity	1.15	0.72	3.39	1.4	1.57
Total Debt / Total Capital	1.14	0.71	3.28	1.38	1.55
LT Debt/Equity	0.78	0.21	3.27	1.05	1.24
Long-Term Debt / Total Capital	0.77	0.21	3.16	1.04	1.22
Total Liabilities / Total Assets	4.27	5.94	23.2	14.79	22.45
EBIT / Interest Expense	-	-	-487.39	-1.39T	-302.03
EBITDA / Interest Expense	-	-	-474.56	-1.33T	-290.48
(EBITDA - Capex) / Interest Expense	-	-	-487.32	-2.46T	-324.39
Total Debt / EBITDA	-0.27	-0.03	-0.06	-0.06	-0.03
Net Debt / EBITDA	21.57	2.92	0.17	3.5	1.3
Total Debt / (EBITDA - Capex)	-0.23	-0.03	-0.06	-0.03	-0.03
Net Debt / (EBITDA - Capex)	19.08	2.86	0.16	1.89	1.16
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	3.85	7.38	-73.52	1.39	-39.2
Gross Profit, 1 Yr. Growth %	-0.06	-9.86	-39.42	100.83	107.37
EBITDA, 1 Yr. Growth %	-1.32	119.31	371.34	60.34	71.04
EBITA, 1 Yr. Growth %	-1.2	116.97	367.76	63.15	70.01
EBIT, 1 Yr. Growth %	-1.12	115.04	365.34	63.15	70.01
Earnings From Cont. Operations, 1 Yr. Growth %	-1.71	114.7	341.43	109.13	32.31
Net Income, 1 Yr. Growth %	-1.71	114.7	332.23	70.46	30.07
Normalized Net Income, 1 Yr. Growth %	-1.97	115.28	390.29	40.47	85.36
Diluted EPS Before Extra, 1 Yr. Growth %	-36.16	56.88	134.32	-13.12	15.48
Accounts Receivable, 1 Yr. Growth %	-1.52	-20.12	-14.53	-90.04	-94.83
Inventory, 1 Yr. Growth %	51.94	42.45	-	-	-
Net Property, Plant and Equip., 1 Yr. Growth %	-0.37	-8.73	1.6T	841.58	31.18
Total Assets, 1 Yr. Growth %	709.47	-8.49	68.51	248.45	-21.73
Tangible Book Value, 1 Yr. Growth %	1.1T	-9.08	-98.6	31.44T	-30.6
Common Equity, 1 Yr. Growth %	1.08T	-9.09	37.58	286.63	-28.77
Cash From Operations, 1 Yr. Growth %	-22.08	171.77	254.9	-50.44	350.88
Capital Expenditures, 1 Yr. Growth %	39.56	-30.18	280.14	4.98T	-76.57
Levered Free Cash Flow, 1 Yr. Growth %	-21.53	44.25	-	879.9	-27.83
Unlevered Free Cash Flow, 1 Yr. Growth %	-21.53	44.25	-	885.47	-28.09
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	17.24	5.6	-	-48.18	-21.49
Gross Profit, 2 Yr. CAGR %	29.64	-5.09	-	300.54	109.93
EBITDA, 2 Yr. CAGR %	-20.26	47.11	-	175.82	65.6
EBITA, 2 Yr. CAGR %	-19.51	46.41	-	176.37	66.55
EBIT, 2 Yr. CAGR %	-19.3	45.82	-	175.54	66.55
Earnings From Cont. Operations, 2 Yr. CAGR %	-18.86	45.27	-	203.84	66.34
Net Income, 2 Yr. CAGR %	-18.86	45.27	-	171.44	48.91
Normalized Net Income, 2 Yr. CAGR %	-19.15	45.27	-	162.44	61.36
Diluted EPS Before Extra, 2 Yr. CAGR %	-34.84	0.08	-	42.68	0.16
Accounts Receivable, 2 Yr. CAGR %	32.07	-11.3	-	-70.83	-92.82
Inventory, 2 Yr. CAGR %	35.98	47.12	-	-	-
Net Property, Plant and Equip., 2 Yr. CAGR %	30.16	-4.64	-	1.17T	251.44
Total Assets, 2 Yr. CAGR %	173.38	172.17	-	142.32	65.14
Tangible Book Value, 2 Yr. CAGR %	199.14	230.95	-	109.91	1.38T
Common Equity, 2 Yr. CAGR %	196.26	227.22	-	130.64	65.95
Cash From Operations, 2 Yr. CAGR %	-25.04	45.52	-	32.62	49.48
Capital Expenditures, 2 Yr. CAGR %	-7.37	-1.29	-	1.29T	244.86
Levered Free Cash Flow, 2 Yr. CAGR %	-25.98	6.39	-	-	165.93
Unlevered Free Cash Flow, 2 Yr. CAGR %	-25.98	6.39	-	-	166.21
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	19.28	13.86	-	-	-45.35
Gross Profit, 3 Yr. CAGR %	40.61	14.85	-	-	227.74
EBITDA, 3 Yr. CAGR %	-21.16	11.72	-	-	135.21
EBITA, 3 Yr. CAGR %	-20.28	12.02	-	-	135.05
EBIT, 3 Yr. CAGR %	-20.06	11.88	-	-	134.58
Earnings From Cont. Operations, 3 Yr. CAGR %	-20.34	12.23	-	-	130.3
Net Income, 3 Yr. CAGR %	-20.34	12.23	-	-	112.41
Normalized Net Income, 3 Yr. CAGR %	-20.41	12.06	-	-	133.72
Diluted EPS Before Extra, 3 Yr. CAGR %	-35.5	-12.67	-	-	32.97
Accounts Receivable, 3 Yr. CAGR %	19.08	11.69	-	-	-83.61
Inventory, 3 Yr. CAGR %	25.65	38.1	-	-	-
Net Property, Plant and Equip., 3 Yr. CAGR %	27.64	15.64	-	-	494.87
Total Assets, 3 Yr. CAGR %	111.39	89.82	-	-	66.26
Tangible Book Value, 3 Yr. CAGR %	140.57	101.13	-	-	45.15
Common Equity, 3 Yr. CAGR %	137.53	99.82	-	-	55.9
Cash From Operations, 3 Yr. CAGR %	-20.81	15.16	-	-	99.42
Capital Expenditures, 3 Yr. CAGR %	4.18	-15.7	-	-	256.24
Levered Free Cash Flow, 3 Yr. CAGR %	-17.89	-7.55	-	-	-
Unlevered Free Cash Flow, 3 Yr. CAGR %	-17.89	-7.55	-	-	-
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	16.08	17.79	-	-	-
Gross Profit, 5 Yr. CAGR %	108.81	40.67	-	-	-
EBITDA, 5 Yr. CAGR %	-7.63	2.75	-	-	-
EBITA, 5 Yr. CAGR %	-8.52	3.24	-	-	-
EBIT, 5 Yr. CAGR %	-8.86	3.22	-	-	-
Earnings From Cont. Operations, 5 Yr. CAGR %	-6.39	3.37	-	-	-
Net Income, 5 Yr. CAGR %	-6.39	3.37	-	-	-
Normalized Net Income, 5 Yr. CAGR %	-7.89	3.36	-	-	-
Diluted EPS Before Extra, 5 Yr. CAGR %	-17.58	-14.52	-	-	-
Accounts Receivable, 5 Yr. CAGR %	27.18	17.24	-	-	-
Inventory, 5 Yr. CAGR %	24.02	34.01	-	-	-
Net Property, Plant and Equip., 5 Yr. CAGR %	36.42	18.74	-	-	-
Total Assets, 5 Yr. CAGR %	31.22	39.34	-	-	-
Tangible Book Value, 5 Yr. CAGR %	32.86	42.61	-	-	-
Common Equity, 5 Yr. CAGR %	32.67	42.03	-	-	-
Cash From Operations, 5 Yr. CAGR %	-6.09	6.18	-	-	-
Capital Expenditures, 5 Yr. CAGR %	-4.47	-13.49	-	-	-
Levered Free Cash Flow, 5 Yr. CAGR %	-3.22	-5.84	-	-	-
Unlevered Free Cash Flow, 5 Yr. CAGR %	-3.21	-5.84	-	-	-